Efficacy and Safety of Pergoveris in Assisted Reproductive Technology—ESPART: rationale and design of a randomised controlled trial in poor ovarian responders undergoing IVF/ICSI treatment

INTRODUCTION: The results of a recent meta-analysis showed that adding recombinant human luteinising hormone (r-hLH) to recombinant human follicle-stimulating hormone (r-hFSH) for ovarian stimulation was beneficial in poor responders, resulting in a 30% relative increase in the clinical pregnancy ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Humaidan, P, Schertz, J, Fischer, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Reproductive Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499676/
https://www.ncbi.nlm.nih.gov/pubmed/26141305
http://dx.doi.org/10.1136/bmjopen-2015-008297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499676/
https://www.ncbi.nlm.nih.gov/pubmed/26141305
http://dx.doi.org/10.1136/bmjopen-2015-008297

Ejemplares similares